tobacco

tobacco Articles

There are few investors who can say they never lost money, but billionaire Stanley Druckenmiller is one of them. And we’re not talking about just squeaking by with a 1% gain, either. His Duquesne...
24/7 Insights E-cigarettes are healthier than traditional cigarettes, but still pose a significant health and addiction risk. Many people use vapes to help quit smoking, and some brands are better...
With corporate profits reaching record highs, some companies have been blamed for jacking up prices under the cover of inflation in what’s been termed “greedflation.” Though PepsiCo is...
Altria's marketing campaign carries the tagline "Moving Beyond Smoking" but a look at its earnings statement confirms how stunningly large its tobacco business is.
The U.S. FDA has agreed to seek a ban on menthol-flavored cigarettes and flavored cigars at the request of more than a dozen public health and civil rights organizations.
Philip Morris International has just announced that it is increasing its regular quarterly dividend by 2.6%.
Altria reported better than expected quarterly results and re-established its 2020 full-year earnings guidance before the markets opened on Tuesday.
Philip Morris reported earnings and revenues that beat second-quarter estimates. Recent FDA approval of the company's IQOS products have boosted share prices as well.
What does it say about long-term industry expectations when a leader in the cannabis field is laying off more employees and closing plants as a restructuring effort?
Counting out a tobacco company has never proved to be a good bet over the long term. Will this time be different?
U.K. tobacco giant Imperial Brands has slashed its dividend. Will American tobacco companies follow suit?
Altria's share price is falling. Its investments have been busts, and hedge funds and shareholders are getting cranky. Even the dividend hasn't made investors happy.
With investments in booze, pot, tobacco and e-cigarettes, Altria has the sin category just about covered. However, the COVID-19 outbreak may indicate that the cost of sin has limits.